Experience

DiscGenics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Small Scale Technical Lead

  • Nov 2021 - Present

  Salt Lake City Metropolitan Area Implemented Quality by Design principles in characterization and scale up of a cell therapy manufacturing process. Specific projects include: • Lead new product development efforts. o Identify market opportunities by defining competitive landscape and market gaps. o Analyze EHR and claims data (IQVIA, Merative, PINC-AI) to assess patient populations, payers, and existing treatment options. o Presented opportunity and pricing recommendations to executive team. • Design… Show more Implemented Quality by Design principles in characterization and scale up of a cell therapy manufacturing process. Specific projects include: • Lead new product development efforts. o Identify market opportunities by defining competitive landscape and market gaps. o Analyze EHR and claims data (IQVIA, Merative, PINC-AI) to assess patient populations, payers, and existing treatment options. o Presented opportunity and pricing recommendations to executive team. • Design, coordinate, and execute process characterization for technology transfer across 200x and 1000x scales. o Lead process characterization planning. o Execute process characterization, which has led to a 77% reduction in process variation, 39% improvement in product quality, and 123% improvement in product yield thus far. • Contributed to a successful Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. • Contributed to a USAMRDC grant application which will bring in $6M to support clinical trials.

• Bioprocess Development Scientist

  • Nov 2019 - Nov 2021

  Salt Lake City, Utah Designed and executed process development studies culminating in process definition and paper publication (https://doi.org/10.1186/s13287-021-02525-0). Presented results in company-wide meetings. Coordinated across groups for bioreactor run execution. Specific responsibilities included: • Managed equipment SAT, IQ/OQ/PQ, and ensuing CAPAs for new equipment installation. • Drafted, edited, reviewed, and approved technical reports, protocols, SOPs, risk assessments, CAPAs, and equipment… Show more Designed and executed process development studies culminating in process definition and paper publication (https://doi.org/10.1186/s13287-021-02525-0). Presented results in company-wide meetings. Coordinated across groups for bioreactor run execution. Specific responsibilities included: • Managed equipment SAT, IQ/OQ/PQ, and ensuing CAPAs for new equipment installation. • Drafted, edited, reviewed, and approved technical reports, protocols, SOPs, risk assessments, CAPAs, and equipment qualification in eQMS system (ETQ Reliance). • Managed equipment, inventory, and personnel for execution of over 24 bioreactor runs in two years. • Aseptically cultured human-derived disc tissue cell populations in both attachment and stirred-tank cultures. • Designed and executed experiments, analyzed data, and summarized conclusions to contribute to process definition project efforts. • Implemented process improvements that shortened analyses from days to minutes and halved operation durations.



CLEARAS

• United States
• Biotechnology
• 1 - 100 Employee

• Technology Development Engineer

  • Apr 2017 - Nov 2019

  Missoula, Montana Area Created and led a cross-functional team tasked with identifying and developing new technology applications. Designed and executed experiments to develop bioreactor technology for algae mitigation of wastewater contaminants. Specific responsibilities included: • Communicated with potential clients to identify needs, pain points, and market opportunities. o Executed demonstrations for clients, adapting technology to niche applications based on specific requirements. o Presented… Show more Created and led a cross-functional team tasked with identifying and developing new technology applications. Designed and executed experiments to develop bioreactor technology for algae mitigation of wastewater contaminants. Specific responsibilities included: • Communicated with potential clients to identify needs, pain points, and market opportunities. o Executed demonstrations for clients, adapting technology to niche applications based on specific requirements. o Presented demonstration results to clients and executives to guide system scale up in unique applications. o Communicated client needs to sales team for further development of sales pipeline. • Identified new market opportunities. o Analyzed aggregate EPA NPDES data to identify water quality standards. o Captured and relayed the voice of the customer to sales staff to coordinate sales initiatives. o Coordinated with internal and external engineers to ensure continuity between technology capabilities and sales initiatives. Show less



University of Montana

• United States
• Higher Education
• 700 & Above Employee

• Research Assistant

  • Aug 2016 - May 2017

  Missoula, Montana Area Earned a research fellowship to execute neurotransmitter secretion studies. Specific responsibilities included: • Aseptically cultured normal rat kidney (NRK) cells. • Executed SDS-PAGE and Western blot techniques for protein quantification. • Analyzed and presented findings to research team and advisors.

• Biochemistry Research Fellow

  • Jan 2015 - May 2017

  Missoula, Montana Area Earned a research fellowship to investigate novel protein function. Designed and executed experiments with advisor approval. Led a section of students during fall semester Introduction to Chemistry. Specific responsibilities included: • Designed and executed shake flask bioreactor runs using BL21 DE3 E. Coli transformed with a pET26b vector for novel protein expression. • Oxidized a custom oligonucleotide via Cr(V) and isolated using HPLC separation. • Executed binding assays to… Show more Earned a research fellowship to investigate novel protein function. Designed and executed experiments with advisor approval. Led a section of students during fall semester Introduction to Chemistry. Specific responsibilities included: • Designed and executed shake flask bioreactor runs using BL21 DE3 E. Coli transformed with a pET26b vector for novel protein expression. • Oxidized a custom oligonucleotide via Cr(V) and isolated using HPLC separation. • Executed binding assays to quantify binding of wild-type and mutated proteins to oxidized oligonucleotide. • Presented and published findings at the University Conference on Undergraduate Research (UMCUR).